18 August 2021 The International Liver Congress™ gives EASL a golden opportunity to engage with international journalists, reaching media in multiple languages, all over the world. This year was no exception. At ILC 2021, EASL issued press releases over three consecutive days with embargos…
9 August 2021 EASL’s monothematic event, Bleeding, Thrombosis, and Vascular Liver Diseases, is coming up soon, 7–9 October 2021. This meeting of blood-meets-liver enthusiasts has a fascinating grassroots history, which EASL member, Dr Stephen Caldwell, has been part of from the start. He told…
In early 2016, the EASL Governing Board initiated a new format for its Schools of Hepatology. In September of the same year, the first pilot of this new format was executed successfully and received overwhelmingly positive feedback from participants. The EASL Schools of Hepatology have been runni…
An Annual Report with a difference, for a year like none other The year 2020 was an extraordinary one, causing major disruption to medical associations and society all around the world. Consequently, our Annual Report 2020 simply cannot be presented in the usual way. We need to tell the story of …
We would like to thank every single participant who took part in this year’s ILC, held 23–26 June 2021. The event brought together almost 6,500 delegates from over 100 countries, who took part in 155 sessions, listened to 566 presentations and viewed 857 posters. And the sharing of knowledge didn…
For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 New data released on trials involving RNAi therapeutics, antivirals and structurally engineered fatty acids to treat NAFLD Friday 25 June 2021 (Geneva, Switzerland)– Leading …
In EASL Studio, we were honoured to keep company with the three 2020 Nobel Laureates, awarded the 2020 Nobel Prize for Physiology and Medicine for their discovery of the hepatitis C virus. They reflected on many thought-provoking topics: the exponential sophistication of research conditions, bet…
For Immediate Release Media Release Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021 Thursday 24 June 2021 (Geneva, Switzerland)– Leading hepatology researchers announced important new developments in hepatitis research at the International Liver Congress 2021…
For Immediate Release Media Release ILC 2021 opens with focus on impact of COVID-19 on global liver disease New data demonstrates that chronic liver disease increased the odds of COVID-19 death by 80% and Pfizer-BioNTech COVID-19 vaccine confers low immunity on people with advanced liver disease …
Every year, on 29 May, we pause to honour World Digestive Health Day: #WDHD2021 This year, the theme is Obesity: An ongoing pandemic. The main goals of the day include providing simple messages for the public, to help them in understanding how obesity affects one’s daily life and its importance …
